Comments
Ipca Laboratories today reported a 80.92 per cent plunge in standalone net profit to Rs 11.69 crore for the quarter ended September 30.
The company had posted a profit of Rs 61.30 crore for the corresponding period of the previous fiscal, Ipca Laboratories said in a regulatory filing.
Standalone total income from operations stood at Rs 749.21 crore for the quarter under consideration as against Rs 780.60 for the same period year ago.
At present, 50 per cent of Ipca Laboratories income comes from exports, which is a main thrust area for the company, it said.
Ipca Laboratories manufactures over 350 formulations and 80 APIs for various therapeutic segments.
Ipca Laboratories shares ended slightly down at Rs 781.80 on the BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.